Infectious complications more than 1 year after liver transplantation: A 3-decade nationwide experience

American Journal of Transplantation

Volumn 11, Issue 2, 2011, Pages 287-295

  Aberg F ^a   Makisalo H ^a   Hockerstedt K ^a   Isoniemi, H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cholangitis; immunosuppression; infection; long term; sepsis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CHOLANGITIS; CYTOMEGALOVIRUS; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FINLAND; FOLLOW UP; HUMAN; INFECTION COMPLICATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS; PNEUMONIA; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; ROUX Y ANASTOMOSIS; SEPSIS; SEX DIFFERENCE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADULT; BACTERIAL INFECTIONS; CHOLANGITIS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; INFECTION; INFECTION CONTROL; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOSES; PNEUMONIA; REGISTRIES; RISK FACTORS; SEPSIS; TIME FACTORS; VIRUS DISEASES;

EID: 79551498491     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03384.x     Document Type: Article

References (28)

1. Fishman JA,. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
2. del Pozo JL,. Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol 2008; 14: 4977-4983.
3. Kusne S, Dummer JS, Singh N, et al,. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988; 67: 132-143.
4. Karam V, Gunson B, Roggen F, et al.,; European Liver Transplant Association. Quality control of the European Liver Transplant Registry: Results of audit visits to the contributing centers. Transplantation 2003; 75: 2167-2173.
5. Mandell GL, Douglas RG, Bennett JE, Dolin R,. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th Ed. Philadelphia, PA: Elsevier Churchill Livingstone, 2005: 1-1726.
6. Bone RC, Balk RA, Cerra FB, et al,. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
7. Lautenschlager I, Halme L, Hockerstedt K, Krogerus L, Taskinen E,. Cytomegalovirus infection of the liver transplant: Virological, histological, immunological, and clinical observations. Transpl Infect Dis 2006; 8: 21-30.
8. Lautenschlager I,. CMV infection, diagnosis and antiviral strategies after liver transplantation. Transpl Int 2009; 22: 1031-1040.
9. Ljungman P, Griffiths P, Paya C,. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
10. Pergam SA, Limaye AP,; AST Infectious Diseases Community of Practice. Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S108-S115.
11. De Pauw B, Walsh TJ, Donnelly JP, et al.,; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
12. Finnish National Vaccination Programme. Available at:. Accessed September 1, 2010.
13. Schmidt SC, Langrehr JM, Hintze RE, Neuhaus P,. Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg 2005; 92: 76-82.
14. Sharma S, Gurakar A, Jabbour N,. Biliary strictures following liver transplantation: Past, present and preventive strategies. Liver Transpl 2008; 14: 759-769.
15. Shah JN, Haigh WG, Lee SP, et al,. Biliary casts after orthotopic liver transplantation: Clinical factors, treatment, biochemical analysis. Am J Gastroenterol 2003; 98: 1861-1867.
16. Hubscher SG,. Transplantation pathology. Semin Liver Dis 2009; 29: 74-90.
17. Duclos-Vallee JC, Sebagh M,. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl 2009; 15 (Suppl 2): S25-S34.
18. Jokinen C, Heiskanen L, Juvonen H, et al,. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-988.
19. Karlsson S, Varpula M, Ruokonen E, et al,. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: The Finnsepsis study. Intensive Care Med 2007; 33: 435-443.
20. Hamandi B, Holbrook AM, Humar A, et al,. Delay of adequate empiric antibiotic therapy is associated with increased mortality among solid-organ transplant patients. Am J Transplant 2009; 9: 1657-1665.
21. Patel R, Badley AD, Larson-Keller J, et al,. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996; 61: 1192-1197.
22. Benten D, Staufer K, Sterneck M,. Orthotopic liver transplantation and what to do during follow-up: Recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol 2009; 6: 23-36.
23. Garbino J, Romand JA, Pittet D, Giostra E, Mentha G, Suter P,. Infection and rejection in liver transplant patients: A 10-year Swiss single-centre experience. Swiss Med Wkly 2005; 135: 587-593.
24. Snydman DR,. Epidemiology of infections after solid-organ transplantation. Clin Infect Dis 2001; 33 (Suppl 1): S5-S8.
25. San Juan R, Aguado JM, Lumbreras C, et al,. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: Data from the RESITRA study group. Am J Transplant 2007; 7: 964-971.
26. Raakow R, Bechstein WO, Kling N, et al,. The importance of late infections for the long-term outcome after liver transplantation. Transpl Int 1996; 9 (Suppl 1): S155-S156.
27. Dorman S, Subramanian A,; AST Infectious Diseases Community of Practice. Nontuberculous mycobacteria in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S63-S69.
28. Clark NM,; AST Infectious Diseases Community of Practice. Nocardia in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S70-S77.